MIRUM PHARMACEUTICALS, INC. (MIRM)
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
📈 **POSITIVE** • High confidence analysis (87%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business